Insider Buying: Parabilis Medicines (NASDAQ:PBLS) Director Acquires 8,435 Shares of Stock

June 17, 2026 by InsiderTrades.com

Key Points

Parabilis Medicines director Alan Sebulsky bought 8,435 shares on Friday, June 12, at an average price of $27.67, totaling about $233,396.
After the purchase, Sebulsky’s holdings rose to 20,935 shares, valued at roughly $579,271, marking a 67.48% increase in his position.
SBebulsky has also been actively buying recently, with additional purchases of 9,065 shares on June 15 and 12,500 shares on June 11, while PBLS stock was up 6.3% and traded at $26.59.

Parabilis Medicines, Inc. (NASDAQ:PBLS - Get Free Report) Director Alan Sebulsky bought 8,435 shares of the company's stock in a transaction dated Friday, June 12th. The stock was bought at an average cost of $27.67 per share, for a total transaction of $233,396.45. Following the acquisition, the director owned 20,935 shares of the company's stock, valued at approximately $579,271.45. This trade represents a 67.48% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Alan Sebulsky also recently made the following trade(s):

On Monday, June 15th, Alan Sebulsky bought 9,065 shares of Parabilis Medicines stock. The stock was bought at an average cost of $26.49 per share, for a total transaction of $240,131.85.
On Thursday, June 11th, Alan Sebulsky acquired 12,500 shares of Parabilis Medicines stock. The shares were acquired at an average cost of $20.00 per share, for a total transaction of $250,000.00.

Parabilis Medicines Stock Up 6.3%

Shares of PBLS stock opened at $26.59 on Wednesday. Parabilis Medicines, Inc. has a 1-year low of $24.51 and a 1-year high of $34.47.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Parabilis Medicines?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Parabilis Medicines and related companies.

From Our Partners